Quantcast

Industry news that matters to you.  Learn more

Aushon BioSystems and AH diagnostics Sign Distribution Deal for Scandinavia

Aushon BioSystems has appointed AH diagnostics as its exclusive distributor in Scandinavia (Sweden, Norway, Finland, Denmark, Iceland), effective November 1, 2012. AH diagnostics will offer Aushon’s complete portfolio of Cira™ platform products including Cirascan™, Ciraplex™ and Cirasoft™ products for multiplex ELISAs.

MD Anderson Cancer Center Acquires Second Aushon 2470 Microarray Printer for its RPPA Core Facility

Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Department of Systems Biology at the MD Anderson Cancer Center has acquired another 2470 microarray printer from Aushon BioSystems. The new 2470 Arrayer will be utilized in the Cancer Center Support Grant (CCSG) Functional Proteomics Reverse Phase Protein Array (RPPA) Facility, a core facility that serves all researchers at MD Anderson Cancer Center, as well as other academic institutions and industries. Extremely high demand for RPPA data and the proven performance of the existing 2470 Arrayer helped drive the acquisition of the additional microarray printer. Combined with the current 2470 on-site, the ability of the Functional Proteomics RPPA Facility to meet the higher throughput demands for biomarker research and diagnostic testing on cancer patients’ protein pathways and drug reaction will be significantly expanded.

Aushon’s Multiplex Immunoassay Platform Used to Validate Panel of Prognostic and Predictive Protein Biomarkers in Recent Phase II and Phase III Studies

Data was presented at the recent American Society of Clinical Oncology’s 2011 Genitourinary Cancers Symposium showing multiple protein biomarkers predictive of clinical benefit and prognostic of disease outcome in patients with advanced or metastatic renal cell cancer.

Aushon LaunchesNew SignaturePLUS System for Multiplex Protein Biomarker Analysis

Aushon announced today the global launch of its next generation SignaturePLUS Imaging and Analysis System. The SignaturePLUS system is designed to meet the cost and performance needs of researchers for accurate, reproducible, and reliable multiplex protein biomarker analysis across pre-clinical, clinical and diagnostics applications in all therapeutic areas.

Aushon Launches New SignaturePLUS System for Multiplex Protein Biomarker Analysis

Aushon announced today the global launch of its next generation SignaturePLUS Imaging and Analysis System. The SignaturePLUS system is designed to meet the cost and performance needs of researchers for accurate, reproducible, and reliable multiplex protein biomarker analysis across pre-clinical, clinical and diagnostics applications in all therapeutic areas.